Daiichi-Ranbaxy row: High Court allows sale of Singh brothers’ firms

Posted On & filed under Top Law News.

The Delhi High Court today allowed the sale of unencumbered shares of the firms of former promoters of India’s Ranbaxy Laboratories Ltd in listed companies to repay the Rs 3,500 crore arbitration award in favour of Japanese pharma major Daiichi Sankyo. Justice Jayant Nath also directed the debtors to fully cooperate with the chartered accountant… Read more »

Andhra HC lifts stay on Ranbaxy, Sun Pharma merger

Posted On & filed under Top Law News.

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by up to 3% in early morning deals after the Andhra Pradesh High Court cleared the decks for the $4-billion deal to go through by lifting the stay. The Andhra Pradesh High Court on Saturday vacated a status quo order it had issued earlier… Read more »

SC dismisses PIL seeking curbs on sale of Ranbaxy drugs

Posted On & filed under Top Law News.

The Supreme Court Tuesday dismissed a petition for prohibiting Ranbaxy from producing and marketing its alleged “adulterated” medicines in the Indian market in the wake of reports of the pharma major having sold misbranded drugs in the US. A bench of Justice A.K.Patnaik and Justice Ranjan Gogoi dismissed the Public Interest Litigation (PIL) by advocate M.L. Sharma, asking him… Read more »